Resources / Identify HER2-low populations: Utilize AI to monitor staining consistency and precisely measure HER2 expression
Oncotopix® Discovery
Duration 26 min
Dirk Vossen and Jeni Caldara, Visiopharm
Identify HER2-low populations: Utilize AI to monitor staining consistency and precisely measure HER2 expression
Details
Duration 26 min
About the presentation

Dive into the world of HER2 expression with Visiopharm’s Chief Diagnostics Officer, Dirk Vossen and Technical Sales Specialist, Jeni Caldara. They’ll be showcasing our innovative two-step solution for interpretation. Confirm your HER2 staining consistency for accurate assessment, and use the vendor agnostic HER2Connect™ app for scoring interpretation. HER2Connect™ has a proven track-record in identifying HER2-low status specimens, a traditionally challenging group to identify through manual interpretation. Don’t miss this opportunity to improve your HER2 interpretation process.

Learning objectives
    • Investigate staining proficiency and discover the only commercial AI technology available to monitor HER2 staining consistency continuously
    • Learn about our IVDR-certified HER2 Breast Cancer APP and see real-world performance data produced at a leading US hospital during a research study
    • Discover how AI-powered decision support can aid in identifying HER2-low specimens
Experts

Dirk Vossen, Chief Diagnostics Officer, Visiopharm

Dirk Vossen, leads a team to develop diagnostic and clinical applications of digital pathology. He has a strong track record of creating value through innovation in digital and computational pathology, covering the full range of development from ideation to validation and certification of medical devices and commercialization strategies. With over a decade of experience as a global leader in building digital pathology solutions, Dirk has expertise in developing whole slide image scanners, image management systems, computational pathology applications, and executing clinical programs. He holds a Ph.D. from the AMOLF Institute and Utrecht University.

Jeni Caldara, Technical Sales Specialist, Visiopharm

Jeni Caldara is an innovative digital pathology professional with 6 years of experience in AI-based image analysis and workflow implementation. With a background in cell biology, she brings creativity to the generation of AI solutions that highlight tissue-specific processes. As a Technical Sales Specialist at Visiopharm, Jeni is based in the Colorado office, where she focuses on translating product offerings and integrating them into existing systems at customer sites.

Topics
Translational US
Questions? We’re here to help.
Talk
Success
Your message has been successfully sent!